Pharma: Page 46


  • Avak Kahvejian
    Image attribution tooltip

    Permission granted by Flagship Pioneering/Avak Kahvejian.

    Image attribution tooltip
    Profile

    Flagship's creative approach to finding the next big idea in biopharma

    Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.

    By Alexandra Pecci • June 1, 2022
  • Colorful DNA double helix.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Cell and gene therapy advances coming fast and furious

    A peek into R&D at the Mass General Brigham network reveals up-and-coming treatments pushing the boundaries of what’s possible in medicine.

    By Kelly Bilodeau • June 1, 2022
  • Trendline

    Artificial intelligence & machine learning

    After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.

    By PharmaVoice staff
  • Monkeypox test
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    SIGA prepares to kick production for monkeypox treatment into high gear

    ‘We’re not bored,’ the company’s science chief says as SIGA Technologies looks to ramp up supplies of its therapeutic.

    By May 31, 2022
  • Sosei Heptares CEO Chris Cargill
    Image attribution tooltip
    Permission granted by Sosei Heptares/Chris Cargill
    Image attribution tooltip
    Q&A // First 90 Days

    First 90 Days: Sosei Heptares’ Chris Cargill

    The company’s new CEO is looking to drive growth through collaboration and transparency.

    By Kim Ribbink • May 31, 2022
  • UNITED STATES - CIRCA 1950s: Interior of Drug Store.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    PBMs under fire for drug prices defend their worth

    A new Senate bill is putting PBMs in the crosshairs of lawmakers — but they argue that they're more than just middlemen.

    By May 26, 2022
  • Businessman on a ladder reaching for the star above clouds.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Making Moves

    Making moves: Inovio, Veru, MindMed and more announce key new hires

    The latest career moves in the biopharma industry from Veru, MindMed, Horizon Therapeutics and Inovio. 

    By Karissa Waddick • May 25, 2022
  • WoW Image
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Ferring Pharmaceutical's Araz Raoof

    Growing up in Iraqi Kurdistan, Raoof says a 'lethal combination' of books and strong women paved her way into STEM.

    By May 25, 2022
  • Close-up Of A Businesswoman Hand Stopping Colorful Dominoes From Falling On Office Desk
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Pharmas can be 'more than medicine' by focusing on preventative care

    Why pharma companies are changing their tack to become more than the products they sell.

    By May 24, 2022
  • medical communications
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Sponsored by ClinicalMind

    3 things medical communications can learn from sales training experts

    Medical communications is moving toward more modern approaches that can make critical information more engaging and better able to "stick".

    May 23, 2022
  • Vidya Viswanathan headshot
    Image attribution tooltip
    Permission granted by Vidya Viswanathan
    Image attribution tooltip

    Tracking trends in healthcare, from tech to patient care

    High-performing leaders honored by the Healthcare Businesswomen’s Association share their views on the future of the industry.

    By May 20, 2022
  • Dozens of orange prescription bottles with white caps and labels layered in a jumple.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Q&A

    Ironwood Pharmaceuticals is charting a course to become a giant in GI

    Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market. 

    By Karissa Waddick • May 19, 2022
  • Image attribution tooltip
    John Moore via Getty Images
    Image attribution tooltip

    A potential COVID-19 EUA could turn this small biotech into a household name

    Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.

    By May 19, 2022
  • SpringWorks Therapeutics chief medical officer Jim Cassidy
    Image attribution tooltip
    Permission granted by SpringWorks/Jim Cassidy
    Image attribution tooltip
    Profile

    Jumping into pharma with big plans at a small company

    SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.

    By Alexandra Pecci • May 17, 2022
  • Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip
    Q&A

    BriOri BioTech sets the stage for the comeback of Vioxx

    With a topical pain-relieving ointment in development, the emerging biotech is aiming to give the tarnished NSAID a new life.

    By Kelly Bilodeau • May 17, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Are digital DCTs the answer for rare diseases?

    How data from EHRs is helping to identify, diagnose and recruit patients to decentralized clinical trials.

    By Kim Ribbink • May 16, 2022
  • Human immunodeficiency virus (HIV) viral disease vaccine under research.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    After 40 years, researchers discover new frontiers in the fight against HIV

    Medical advances in the last two decades may now provide scientists with the right toolbox to target the long-elusive virus.

    By Karissa Waddick • May 16, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Sponsored by GoodRx

    A better approach to boosting patient engagement

    GoodRx solutions help biopharma brands overcome common barriers & increase patient engagement.

    May 16, 2022
  • Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma
    Image attribution tooltip

    Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees. 

    Image attribution tooltip
    Opinion

    Why 'soft' skills matter in the new era of leadership

    Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.

    By May 12, 2022
  • This week's Woman of the Week Michelle Marlborough of AiCure shares her journey and leadership lessons.
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: AiCure's Michelle Marlborough

    As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.

    By May 11, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    In the hot pharma talent market, execs battle these recruitment misconceptions

    One of the top recruiting firms in life sciences weighs in on how companies can attract the next wave of rising stars.

    By May 11, 2022
  • A doctor holding tablets of medicine explains options to a patient in a hospital room.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    It's time to acknowledge access as a prescribing barrier

    A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs. 

    By Karissa Waddick • May 11, 2022
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA draft guidance may turn diversity in clinical trials from nice-to-have into a must-have

    New guidance from the FDA will ‘up the ante’ for diversity considerations. Here’s how your company can prepare.

    By Kelly Bilodeau • May 10, 2022
  • Replimune CEO and co-founder Philip Astley-Sparke
    Image attribution tooltip
    Permission granted by Replimune/Philip Astley-Sparke
    Image attribution tooltip

    Where hope and uncertainty meet: A cutting-edge cancer developer's winding road

    Replimune is on the precipice of a new kind of cancer treatment, but its CEO knows something about ambiguity.

    By Alexandra Pecci • May 9, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip
    Sponsored by CorEvitas

    Understanding real-world data in the real world

    Real-world data (RWD) and real-world evidence (RWE) are valuable across the entire pharmaceutical product lifecycle, from examining patient outcomes to supporting disease education and awareness and beyond. 

    May 9, 2022
  • Close up storyboard content planning of production media of the Blogger or Vlog and the laptop and camera on the desk work.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Pharma's solution to the digital advertising dilemma? Storytelling

    Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.

    By Karissa Waddick • May 5, 2022